骨骼发育不良市场：按类型、治疗方法和最终用户划分 - 全球预测 2023-2030

全球骨骼发育不良市场预计到 2023 年将达到 28.318 亿美元，年复合成长率为 7.19%，预计到 2030 年将出现惊人的增长，达到 46.1007 亿美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球骨骼发育不良市场至关重要。透过检验业务策略和产品满意度等关键指标，它可以对供应商进行全面评估，使用户能够根据自己的特定需求做出资讯的决策。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球骨骼发育不良市场规模及预测为何？

2.在预测期内，COVID-19 对全球骨骼发育不良市场的阻碍因素与影响有哪些？

3.在预测期内，全球骨骼发育不良市场需要投资哪些产品/细分市场/应用/领域？

4.你们在全球骨骼发育不良市场的竞争策略是什么？

5.全球骨骼发育不良市场的技术趋势和法律规范是什么？

6.全球骨骼发育不良市场主要供应商的市占率为何？

7. 哪些型态和策略性措施被认为适合进入全球骨骼发育不良市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 先天性疾病和出生缺陷呈上升趋势
    • 增加荷尔蒙治疗以治疗骨骼发育不良
    • 关注骨骼发育不良设备的技术进步
  • 抑制因素
    • 骨骼发育不良的治疗选择有限
  • 机会
    • 增加骨骼发育不良药物开发的研发和临床试验
  • 任务
    • 缺乏有效的诊断工具和技术
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章骨骼发育不良市场：依类型

• 软骨发育不全
• 进行性肌肉骨化症
• 低磷酸酯酶症
• 多发性骨软骨瘤
• X连锁低血磷症

第7章依治疗分類的骨骼发育不良市场

• 剂量
• 外科手术

第8章骨骼发育不良市场：依最终使用者分类

• 诊所
• 医院

第9章北美及南美骨骼发育不良市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第10章亚太骨骼发育不良市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第11章欧洲、中东和非洲骨骼发育不良市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第12章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

• 讨论指南
• 关于许可证和定价

The Global Skeletal Dysplasia Market is forecasted to grow significantly, with a projected USD 2,831.80 million in 2023 at a CAGR of 7.19% and expected to reach a staggering USD 4,610.07 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Skeletal Dysplasia Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Skeletal Dysplasia Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Achondroplasia, Fibrodysplasia Ossificans Progressive, Hypophosphatasia, Multiple Osteochondromas, and X-linked Hypophosphatemia. The Fibrodysplasia Ossificans Progressive is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Medication and Surgery. The Medication is projected to witness significant market share during forecast period.

Based on End User, market is studied across Clinic and Hospital. The Hospital is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Skeletal Dysplasia Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Skeletal Dysplasia Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Skeletal Dysplasia Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Skeletal Dysplasia Market?

4. What is the competitive strategic window for opportunities in the Global Skeletal Dysplasia Market?

5. What are the technology trends and regulatory frameworks in the Global Skeletal Dysplasia Market?

6. What is the market share of the leading vendors in the Global Skeletal Dysplasia Market?

7. What modes and strategic moves are considered suitable for entering the Global Skeletal Dysplasia Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Skeletal Dysplasia Market, by Type, 2022 vs 2030
• 4.3. Skeletal Dysplasia Market, by Treatment, 2022 vs 2030
• 4.4. Skeletal Dysplasia Market, by End User, 2022 vs 2030
• 4.5. Skeletal Dysplasia Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing congenital disorders and birth defects
    • 5.1.1.2. Growth in hormone therapy for treatment of skeletal dysplasia
    • 5.1.1.3. Focus on the technological advancements in skeletal dysplasia devices
  • 5.1.2. Restraints
    • 5.1.2.1. Limited treatment options available for skeletal dysplasia
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing R&D and clinical trial for drug development of skeletal dysplasia
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of efficient diagnostic measures and technologies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Skeletal Dysplasia Market, by Type

• 6.1. Introduction
• 6.2. Achondroplasia
• 6.3. Fibrodysplasia Ossificans Progressive
• 6.4. Hypophosphatasia
• 6.5. Multiple Osteochondromas
• 6.6. X-linked Hypophosphatemia

7. Skeletal Dysplasia Market, by Treatment

• 7.1. Introduction
• 7.2. Medication
• 7.3. Surgery

8. Skeletal Dysplasia Market, by End User

• 8.1. Introduction
• 8.2. Clinic
• 8.3. Hospital

9. Americas Skeletal Dysplasia Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Skeletal Dysplasia Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Skeletal Dysplasia Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. SKELETAL DYSPLASIA MARKET RESEARCH PROCESS
• FIGURE 2. SKELETAL DYSPLASIA MARKET SIZE, 2022 VS 2030
• FIGURE 3. SKELETAL DYSPLASIA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
• FIGURE 6. SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2022 VS 2030 (%)
• FIGURE 7. SKELETAL DYSPLASIA MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. SKELETAL DYSPLASIA MARKET DYNAMICS
• FIGURE 9. SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS SKELETAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES SKELETAL DYSPLASIA MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC SKELETAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. SKELETAL DYSPLASIA MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. SKELETAL DYSPLASIA MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. SKELETAL DYSPLASIA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. SKELETAL DYSPLASIA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. SKELETAL DYSPLASIA MARKET SIZE, BY ACHONDROPLASIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. SKELETAL DYSPLASIA MARKET SIZE, BY FIBRODYSPLASIA OSSIFICANS PROGRESSIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. SKELETAL DYSPLASIA MARKET SIZE, BY HYPOPHOSPHATASIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. SKELETAL DYSPLASIA MARKET SIZE, BY MULTIPLE OSTEOCHONDROMAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. SKELETAL DYSPLASIA MARKET SIZE, BY X-LINKED HYPOPHOSPHATEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 11. SKELETAL DYSPLASIA MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. SKELETAL DYSPLASIA MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 14. SKELETAL DYSPLASIA MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. SKELETAL DYSPLASIA MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS SKELETAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. CANADA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. CANADA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 28. CANADA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES SKELETAL DYSPLASIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. ASIA-PACIFIC SKELETAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. AUSTRALIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. CHINA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CHINA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 45. CHINA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. INDIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. INDIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 48. INDIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. INDONESIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. JAPAN SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MALAYSIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. PHILIPPINES SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. SINGAPORE SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. SOUTH KOREA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. TAIWAN SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. THAILAND SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. VIETNAM SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. EUROPE, MIDDLE EAST & AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. DENMARK SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EGYPT SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. FINLAND SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. FRANCE SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. GERMANY SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. ISRAEL SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. ITALY SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ITALY SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 100. ITALY SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. NETHERLANDS SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. NIGERIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. NORWAY SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 110. POLAND SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. POLAND SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 112. POLAND SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. QATAR SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. QATAR SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 115. QATAR SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. RUSSIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 119. SAUDI ARABIA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. SPAIN SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. SWEDEN SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 131. SWITZERLAND SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 134. TURKEY SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. UNITED ARAB EMIRATES SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED KINGDOM SKELETAL DYSPLASIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM SKELETAL DYSPLASIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM SKELETAL DYSPLASIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. SKELETAL DYSPLASIA MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 144. SKELETAL DYSPLASIA MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 145. SKELETAL DYSPLASIA MARKET LICENSE & PRICING